Browsing by Author "Buckel, E."

Now showing 1 - 7 of 7
  • Thumbnail Image
    Item
    Chilean experience in liver transplantation for acute liver failure in children
    (2010) Uribe, M.; Alba, A.; Hunter, B.; Valverde, C.; Godoy, J.; Ferrario, M.; Buckel, E.; Cavallieri, S.; Rebolledo Acevedo, Rolando Arturo; Herzog, C.; Calabrán, L.; Flores, L.; Soto, P.
    Background: Acute liver failure (ALF) in children is a life-threatening condition, associated with high mortality, and in almost one third of the cases, with no other therapeutic option than orthotopic liver transplant (OLT). The aim of this study was to present our experience with OLT for ALF in pediatric patients in Chile. Patients fulfilling the criteria for ALF who were transplanted in our centers were prospectively included in an excel Microsoft database. We analyzed demographics, etiology, surgical techniques, complications, and long-term results. Patients and Methods: Between 1994 and 2009, we transplanted 52 pediatric patients with ALF. The most frequent known etiology was acute hepatitis A in 9 cases (18%), but in 26 cases (50%) it was impossible to determine the etiology. Thirty- one patients were males (63%). The overall mean age was 7.5 years and the mean weight, 28.1 kg. Thirty-five (67%) received a cadaveric graft. Among them in 18 cases (34%) the liver had to be reduced but 17 (33%) received whole livers. There were 17 (33%) recipients of living-related livers. Twenty-two patients needed reoperation, including 13 due to surgical complications (59%) and 9 (41%) as planned interventions. Ten patients were retransplanted. Results: Actuarial survival of patients at 1 year was 80% and at 5 and 10 years, 72%. Graft survival at 1 year was 79%, at 5 years 69%, and at 10 years 50%. Conclusion: We have reported a series of pediatric liver transplant patients due to ALF whose results were comparable to other reported series. Living donor transplantation for ALF should be considered and offers a low morbidity rate without mortality.
  • No Thumbnail Available
    Item
    Laparoscopic Liver Resection: A South American Experience with 2887 Cases
    (2020) Pekolj, J.; Claria Sanchez, R.; Salceda, J.; Maurette, R. J.; Schelotto, P. B.; Pierini, L.; Canepa, E.; Moro, M.; Stork, G.; Resio, N.; Neffa, J.; Mc Cormack, L.; Quinonez, E.; Raffin, G.; Obeide, L.; Fernandez, D.; Pfaffen, G.; Salas, C.; Linzey, M.; Schmidt, G.; Ruiz, S.; Alvarez, F.; Buffaliza, J.; Maroni, R.; Campi, O.; Bertona, C.; de Santibanes, M.; Mazza, O.; Belotto de Oliveira, M.; Diniz, A. L.; Enne de Oliveira, M.; Machado, M. A.; Kalil, A. N.; Pinto, R. D.; Rezende, A. P.; Ramos, E. J. B.; Talvane T. Oliveira, A.; Torres, O. J. M.; Jarufe Cassis, N.; Buckel, E.; Quevedo Torres, R.; Chapochnick, J.; Sanhueza Garcia, M.; Munoz, C.; Castro, G.; Losada, H.; Vergara Suarez, F.; Guevara, O.; Davila, D.; Palacios, O.; Jimenez, A.; Poggi, L.; Torres, V.; Fonseca, G. M.; Kruger, J. A. P.; Coelho, F. F.; Russo, L.; Herman, P.
    Background Laparoscopic liver resections (LLR) have been increasingly performed in recent years. Most of the available evidence, however, comes from specialized centers in Asia, Europe and USA. Data from South America are limited and based on single-center experiences. To date, no multicenter studies evaluated the results of LLR in South America. The aim of this study was to evaluate the experience and results with LLR in South American centers. Methods From February to November 2019, a survey about LLR was conducted in 61 hepatobiliary centers in South America, composed by 20 questions concerning demographic characteristics, surgical data, and perioperative results. Results Fifty-one (83.6%) centers from seven different countries answered the survey. A total of 2887 LLR were performed, as follows: Argentina (928), Brazil (1326), Chile (322), Colombia (210), Paraguay (9), Peru (75), and Uruguay (8). The first program began in 1997; however, the majority (60.7%) started after 2010. The percentage of LLR over open resections was 28.4% (4.4-84%). Of the total, 76.5% were minor hepatectomies and 23.5% major, including 266 right hepatectomies and 343 left hepatectomies. The conversion rate was 9.7%, overall morbidity 13%, and mortality 0.7%. Conclusions This is the largest study assessing the dissemination and results of LLR in South America. It showed an increasing number of centers performing LLR with the promising perioperative results, aligned with other worldwide excellence centers.
  • Thumbnail Image
    Item
    Late Acute Humoral Rejection in Low-Risk Renal Transplant Recipients Induced With an Interleukin-2 Receptor Antagonist and Maintained With Standard Therapy: Preliminary Communication
    (ELSEVIER SCIENCE INC, 2011) Morales, J.; Contreras, L.; Zehnder, C.; Pinto, V.; Elberg, M.; Araneda, S.; Herzog, C.; Calabran, L.; Aguilo, J.; Ferrario, M.; Buckel, E.; Fierro, J. A.
    Low-risk renal transplant recipients treated with standard immunosuppressive therapy including interleukin-2 receptor (IL-2R) antagonist show a low incidence of early rejection episodes but few reports have examined the incidence and severity of late rejection processes. This study evaluated retrospectively cellular and antibody-mediated rejection (AMR) among 42 recipients selected because they showed low panel-reactive-antibodies, short cold ischemia time, no delayed graft function, and therapy including basiliximab (Simulect) induction. The mean observation time was 6.6 years. Sixty-seven percent of donors were deceased. Ten-year patient and death-censored graft survivals were 81% and 78%, respectively. Seven patients lost their kidneys due to nonimmunologic events. The seven recipients who experienced cellular rejection episodes during the first posttransplant year had them reversed with steroids. Five patients displayed late acute AMR causing functional deterioration in four cases including 1 graft loss. De novo sensitization occurred in 48% of recipients including patients without clinical rejection. In conclusion, long-term follow-up of kidney transplant recipients selected by a low immunologic risk showed a persistent risk of de novo sensitization evolving to acute AMR in 11% of cases. Although immunologic events were related to late immunosuppressive reduction, most graft losses were due to nonimmunologic factors.
  • Thumbnail Image
    Item
    Liver transplantation in children weighing less than 10 kg.: chilean experience
    (2013) Uribe, M.; Alba, A.; Hunter, B.; González, G.; Godoy, J.; Ferrario, M.; Buckel, E.; Cavallieri, S.; Heine, C.; Rebolledo Acevedo, Rolando Arturo; Auad, H.; Acuña, C.
  • Thumbnail Image
    Item
    Pediatric liver transplantation experience and outcome in Chile
    (2013) Acuña, C.; Zuleta, R.; Dalmazzo, R.; Valverde, C.; Uribe, M.; Alba, A.; Buckel, E.; Hunter, B.; González, G.; Godoy, J.; Ferrario, M.; Cavallieri, S.; Campos, M.; Pizarro, F.; Wash, A.; Ferrón, S.; Díaz, V.; Macho, L.; Herzog, C.; Calabrán, L.; Flores, L.; Soto, P.; Heine, C.; Rebolledo Acevedo, Rolando Arturo; Auad, H.
  • No Thumbnail Available
    Item
    Significant transfer of surgical skills obtained with an advanced laparoscopic training program to a laparoscopic jejunojejunostomy in a live porcine model: Feasibility of learning advanced laparoscopy in a general surgery residency
    (2012) Varas Cohen, Julian Emanuel; Mejía, R.; Riquelme, A.; Maluenda, F.; Buckel, E.; Salinas, J.; Martínez, J.; Aggarwal, R.; Jarufe, N.; Boza, C.
  • Thumbnail Image
    Item
    Smartphone application supplements laparoscopic training through simulation by reducing the need for feedback from expert tutors
    (2019) Quezada, J.; Achurra, P.; Asbun, D.; Polom, K.; Roviello, F.; Buckel, E.; Inzunza, M.; Escalona, G.; Jarufe, N.; Varas Cohen, Julian Emanuel